Skip to main content

Bone Marrow Transplantation in Children and Quality of Life in Long-Term Survivors

  • Chapter
Childhood Leukemia: Present Problems and Future Prospects

Abstract

Allogeneic bone marrow transplantation (BMT) has been performed in 70 patients with hematological malignancies or other various diseases during the last seven years at Tokai University. The projected survival rates of HLA genotypically compatible marrow recipients were 100% for chronic myelogenous leukemia (N = 10), 81.5% for acute nonlymphocytic leukemia (N = 13), 37.6% for acute lymphocytic leukemia (N = 14), 40.0% for solid tumors (N = 5) and 100% for non-neoplastic diseases (N = 12). Survival rates of patients who received marrow grafts from donors other than HLA genotypically identical siblings were 18.8% for leukemia (N = 8) and 100% for non-neoplastic diseases (N = 6). The quality of life in pediatric long-term surviving marrow recipients has been good and acceptable in general. Profound common abnormalities among survivors are long-lasting hypogonadism due to radiation and subclinical impairment of lung function in the first several months post-BMT. About two thirds of children experienced a transient decrease in growth velocity in the immediate post-transplant period.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Champlin, R. and Gale, R.P.: Acute myelogenous leukemia: recent advances in therapy. Blood 69: 1551–1562, 1987.

    PubMed  CAS  Google Scholar 

  2. Champlin, R. and Gale, R.P.: Acute lymphoblastic leukemia: recent advances in biology and therapy. Blood 73: 2051–2066, 1989.

    PubMed  CAS  Google Scholar 

  3. Barrett, AJ., Horowitz, M.M., Gale, R.P. et al: Marrow transplantation for acute lymphoblastic leukemia: factors affecting relapse and survival. Blood 74: 862–871, 1989.

    PubMed  CAS  Google Scholar 

  4. Sanders, J.E., Thomas, E.D., Buckner, CD. et al: Marrow transplantation for children in first remission of acute nonlymphoblastic leukemia: an update. Blood 66: 460–462, 1985

    PubMed  CAS  Google Scholar 

  5. McGlave, P.B., Haake, RJ., Bostrom, B.C. et al: Allogeneic bone marrow transplantation for acute nonlymphocytic leukemia in first remission. Blood 72: 1512–1517, 1988.

    PubMed  CAS  Google Scholar 

  6. Coccia, P.F., Strandjord, S.E., Warkentin, P.I. et al: High-dose cytosine arabinoside and fractionated total body irradiation: an improved preparative regimen for bone marrow transplantation of children with acute lymphoblastic leukemia in remission. Blood 71: 888–893, 1988.

    PubMed  CAS  Google Scholar 

  7. Blume, K.G., Forman, SJ., O’Donnell, M.R. et al: Total body irradiation and high-dose etoposide: a new preparatory regimen for bone marrow transplantation in patients with advanced hematologic malignancies. Blood 69: 1015–1020, 1987.

    PubMed  CAS  Google Scholar 

  8. Gassmann, W., Uharek, L, Wottge, H.U. et al: Comparison of cyclophosphamide, cytarabine and etoposide as immunosuppressive agents before allogeneic bone marrow transplantation. Blood 72: 1574–1579, 1988.

    PubMed  CAS  Google Scholar 

  9. Sanders, J.E., Pritchard, S., Mahoney, P. et al.: Growth and development following marrow transplantation for leukemia. Blood 68: 1129–1135, 1986.

    PubMed  CAS  Google Scholar 

  10. Johnson, F.L., Sanders, J.E., Ruggiero, M. et al.: Bone marrow transplantation for the treatment of acute nonlymphoblastic leukemia in children aged less than 2 years. Blood 71: 1277–1280, 1988.

    PubMed  CAS  Google Scholar 

  11. Bushhouse, S., Ramsay, N.K.C., Pescovitz, O.H. et al.: Growth in children following irradiation for bone marrow transplantation. Am. J. Pediatr. Hematol. Oncol. 11: 134–140, 1989.

    PubMed  CAS  Google Scholar 

  12. Sanders, J.E., Buckner, CD., Leonard, J.M. et al.: Late effects on gonadal function of cyclophosphamide, total body irradiation, and marrow transplantation. Transplantation 36: 252–255, 1983.

    Article  PubMed  CAS  Google Scholar 

  13. Sklar, C.A., Kim, T.H. and Ramsay, N.K.C.: Testicular function following bone marrow transplantation performed during or after puberty. Cancer 53: 1498–1501, 1989.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Consortia

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer Science+Business Media New York

About this chapter

Cite this chapter

Kato, S. et al. (1991). Bone Marrow Transplantation in Children and Quality of Life in Long-Term Survivors. In: Kobayashi, N., Akera, T., Mizutani, S. (eds) Childhood Leukemia: Present Problems and Future Prospects. Developments in Oncology, vol 65. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3898-1_19

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-3898-1_19

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-6739-0

  • Online ISBN: 978-1-4615-3898-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics